vs

Side-by-side financial comparison of BRANDYWINE REALTY TRUST (BDN) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $127.0M, roughly 1.5× BRANDYWINE REALTY TRUST). BRANDYWINE REALTY TRUST runs the higher net margin — -38.4% vs -57.9%, a 19.4% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs 4.5%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs 0.7%).

Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

BDN vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.5× larger
NEO
$186.7M
$127.0M
BDN
Growing faster (revenue YoY)
NEO
NEO
+6.6% gap
NEO
11.1%
4.5%
BDN
Higher net margin
BDN
BDN
19.4% more per $
BDN
-38.4%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
0.7%
BDN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BDN
BDN
NEO
NEO
Revenue
$127.0M
$186.7M
Net Profit
$-48.8M
$-108.0M
Gross Margin
43.3%
Operating Margin
1.2%
46.9%
Net Margin
-38.4%
-57.9%
Revenue YoY
4.5%
11.1%
Net Profit YoY
-80.4%
42.0%
EPS (diluted)
$-0.28
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDN
BDN
NEO
NEO
Q1 26
$127.0M
$186.7M
Q4 25
$121.0M
$190.2M
Q3 25
$121.4M
$187.8M
Q2 25
$120.6M
$181.3M
Q1 25
$121.5M
$168.0M
Q4 24
$121.9M
$172.0M
Q3 24
$131.8M
$167.8M
Q2 24
$125.3M
$164.5M
Net Profit
BDN
BDN
NEO
NEO
Q1 26
$-48.8M
$-108.0M
Q4 25
$-36.7M
Q3 25
$-25.9M
$-27.1M
Q2 25
$-88.7M
$-45.1M
Q1 25
$-27.0M
$-25.9M
Q4 24
$-44.5M
Q3 24
$-165.2M
$-17.7M
Q2 24
$30.2M
$-18.6M
Gross Margin
BDN
BDN
NEO
NEO
Q1 26
43.3%
Q4 25
61.3%
43.8%
Q3 25
62.6%
42.8%
Q2 25
62.4%
42.6%
Q1 25
60.8%
43.6%
Q4 24
61.2%
44.9%
Q3 24
64.9%
44.6%
Q2 24
63.1%
44.1%
Operating Margin
BDN
BDN
NEO
NEO
Q1 26
1.2%
46.9%
Q4 25
22.8%
-7.1%
Q3 25
20.8%
-14.4%
Q2 25
-34.3%
-26.3%
Q1 25
12.5%
-16.6%
Q4 24
18.0%
-10.7%
Q3 24
-7.2%
-12.6%
Q2 24
15.5%
-13.3%
Net Margin
BDN
BDN
NEO
NEO
Q1 26
-38.4%
-57.9%
Q4 25
-30.3%
Q3 25
-21.3%
-14.4%
Q2 25
-73.5%
-24.9%
Q1 25
-22.2%
-15.4%
Q4 24
-36.5%
Q3 24
-125.4%
-10.5%
Q2 24
24.1%
-11.3%
EPS (diluted)
BDN
BDN
NEO
NEO
Q1 26
$-0.28
$-0.13
Q4 25
$-0.21
Q3 25
$-0.15
Q2 25
$-0.51
Q1 25
$-0.16
Q4 24
$-0.25
Q3 24
$-0.96
Q2 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDN
BDN
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$36.2M
$146.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$828.8M
Total Assets
$3.6B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDN
BDN
NEO
NEO
Q1 26
$36.2M
$146.1M
Q4 25
$32.3M
$159.6M
Q3 25
$75.5M
$164.1M
Q2 25
$122.6M
$154.7M
Q1 25
$29.4M
$346.2M
Q4 24
$90.2M
$367.0M
Q3 24
$36.5M
$362.0M
Q2 24
$30.4M
$355.1M
Total Debt
BDN
BDN
NEO
NEO
Q1 26
Q4 25
$2.6B
$341.9M
Q3 25
$2.3B
Q2 25
$2.3B
Q1 25
$2.2B
Q4 24
$2.2B
$541.1M
Q3 24
$2.3B
Q2 24
$2.2B
Stockholders' Equity
BDN
BDN
NEO
NEO
Q1 26
$828.8M
Q4 25
$792.7M
$836.6M
Q3 25
$841.5M
$838.3M
Q2 25
$879.8M
$854.0M
Q1 25
$993.6M
$888.3M
Q4 24
$1.0B
$902.3M
Q3 24
$1.1B
$908.2M
Q2 24
$1.3B
$915.9M
Total Assets
BDN
BDN
NEO
NEO
Q1 26
$3.6B
$1.3B
Q4 25
$3.6B
$1.4B
Q3 25
$3.3B
$1.4B
Q2 25
$3.4B
$1.4B
Q1 25
$3.4B
$1.6B
Q4 24
$3.5B
$1.6B
Q3 24
$3.6B
$1.6B
Q2 24
$3.8B
$1.6B
Debt / Equity
BDN
BDN
NEO
NEO
Q1 26
Q4 25
3.23×
0.41×
Q3 25
2.70×
Q2 25
2.63×
Q1 25
2.23×
Q4 24
2.13×
0.60×
Q3 24
2.06×
Q2 24
1.73×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDN
BDN
NEO
NEO
Operating Cash FlowLast quarter
$-8.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDN
BDN
NEO
NEO
Q1 26
$-8.1M
Q4 25
$116.7M
$1.3M
Q3 25
$47.5M
$8.9M
Q2 25
$34.4M
$20.3M
Q1 25
$6.3M
$-25.3M
Q4 24
$181.1M
$9.8M
Q3 24
$52.2M
$9.2M
Q2 24
$48.2M
$13.9M
Free Cash Flow
BDN
BDN
NEO
NEO
Q1 26
Q4 25
$-6.5M
Q3 25
$570.0K
Q2 25
$14.0M
Q1 25
$-29.8M
Q4 24
$-1.8M
Q3 24
$-1.6M
Q2 24
$814.0K
FCF Margin
BDN
BDN
NEO
NEO
Q1 26
Q4 25
-3.4%
Q3 25
0.3%
Q2 25
7.7%
Q1 25
-17.8%
Q4 24
-1.0%
Q3 24
-0.9%
Q2 24
0.5%
Capex Intensity
BDN
BDN
NEO
NEO
Q1 26
Q4 25
4.1%
Q3 25
4.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
6.7%
Q3 24
6.4%
Q2 24
8.0%
Cash Conversion
BDN
BDN
NEO
NEO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDN
BDN

Rents$120.7M95%
Third party management fees, labor reimbursement and leasing$4.7M4%

NEO
NEO

Segment breakdown not available.

Related Comparisons